Guangzhou Wondfo Biotech Co Ltd (300482) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.021x

Based on the latest financial reports, Guangzhou Wondfo Biotech Co Ltd (300482) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥116.99 Million ≈ $17.12 Million USD) by net assets (CN¥5.56 Billion ≈ $813.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300482 equity financing ratio to measure how much of total assets are equity-financed.

Guangzhou Wondfo Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Guangzhou Wondfo Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Guangzhou Wondfo Biotech Co Ltd (300482) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Guangzhou Wondfo Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangzhou Wondfo Biotech Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Chengdu Leejun Industrial Co Ltd SHE:002651	0.000x
Inhibrx Biosciences, Inc. NASDAQ:INBX	-3.769x
Metropolitan Kentjana Tbk JK:MKPI	0.034x
Sensirion Holding AG SW:SENS	0.098x
Astec Industries Inc NASDAQ:ASTE	0.062x
Anhui Water Resources Development Co Ltd SHG:600502	0.019x
Shenzhen Minkave Technology Co Ltd SHE:300506	0.013x
Acbel Polytech Inc TW:6282	0.013x

Annual Cash Flow Conversion Efficiency for Guangzhou Wondfo Biotech Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Guangzhou Wondfo Biotech Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Guangzhou Wondfo Biotech Co Ltd (300482) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥5.47 Billion ≈ $800.95 Million	CN¥463.04 Million ≈ $67.76 Million	0.085x	+32.15%
2024-12-31	CN¥5.65 Billion ≈ $826.81 Million	CN¥361.71 Million ≈ $52.93 Million	0.064x	-23.90%
2023-12-31	CN¥4.61 Billion ≈ $675.26 Million	CN¥388.19 Million ≈ $56.80 Million	0.084x	-77.31%
2022-12-31	CN¥4.54 Billion ≈ $663.99 Million	CN¥1.68 Billion ≈ $246.15 Million	0.371x	+95.36%
2021-12-31	CN¥3.50 Billion ≈ $512.76 Million	CN¥664.93 Million ≈ $97.30 Million	0.190x	-46.50%
2020-12-31	CN¥2.99 Billion ≈ $438.06 Million	CN¥1.06 Billion ≈ $155.38 Million	0.355x	+181.66%
2019-12-31	CN¥2.46 Billion ≈ $360.06 Million	CN¥309.86 Million ≈ $45.34 Million	0.126x	+9.42%
2018-12-31	CN¥2.15 Billion ≈ $314.82 Million	CN¥247.61 Million ≈ $36.23 Million	0.115x	-18.89%
2017-12-31	CN¥1.19 Billion ≈ $174.13 Million	CN¥168.85 Million ≈ $24.71 Million	0.142x	+8.28%
2016-12-31	CN¥854.75 Million ≈ $125.08 Million	CN¥112.01 Million ≈ $16.39 Million	0.131x	-30.35%
2015-12-31	CN¥700.64 Million ≈ $102.53 Million	CN¥131.81 Million ≈ $19.29 Million	0.188x	-43.56%
2014-12-31	CN¥313.43 Million ≈ $45.86 Million	CN¥104.47 Million ≈ $15.29 Million	0.333x	-20.24%
2013-12-31	CN¥241.47 Million ≈ $35.33 Million	CN¥100.91 Million ≈ $14.77 Million	0.418x	+1.91%
2012-12-31	CN¥182.48 Million ≈ $26.70 Million	CN¥74.84 Million ≈ $10.95 Million	0.410x	+148.81%
2011-12-31	CN¥144.61 Million ≈ $21.16 Million	CN¥23.83 Million ≈ $3.49 Million	0.165x	--

About Guangzhou Wondfo Biotech Co Ltd

SHE:300482 China Medical Devices

Market Cap

$1.21 Billion

CN¥8.26 Billion CNY

Market Cap Rank

#8002 Global

#1791 in China

Share Price

CN¥17.64

Change (1 day)

+1.15%

52-Week Range

CN¥15.69 - CN¥25.56

All Time High

CN¥92.01